En español

Increased HAART coverage associated with a decrease in morbidity, mortality, and transmission of HIV

In a new NIDA-funded study, expansion of HIV treatment in British Columbia led to improved HIV/AIDS health outcomes and decreased HIV transmission. The Treatment as Prevention strategy, launched by the British Columbia Centre for Excellence in HIV/AIDS, utilizes widespread HIV testing and fully-funded, immediate access to Highly Active Antiretroviral Therapy (HAART) for patients with HIV/AIDS. The study, published February 12 in PLOS One, found that the Treatment as Prevention strategy resulted in an 80% decrease in AIDS incidence, an 80% decrease in HIV-related mortality, and a 66% decrease in new HIV diagnoses. Also, for every 1% increase in the number of individuals suppressed on HAART, the estimated HIV incidence also decreased by 1%.

The findings of this study show that HIV/AIDS health outcomes will improve and fewer people will become infected with HIV/AIDS when there are fewer financial blockages to care like HAART.

For a copy of the study, go to: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0087872

This page was last updated February 2014

Get this Publication

    Receive Latest Science Articles in your Email!
    You will only receive messages related to Latest Science

    Contact Press Office

    (8:30-5:30 ET)